Journals / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 5

Allergic diseases in the elderly population: a single-center experience

Pages
2631–2640
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There is a need to develop specific guidelines for the diagnosis of allergic diseases in the elderly.Key words: Elderly, allergic diseases, allergic rhinitis, drug hypersensitivity reactions, hymenoptera venom allergy, anaphylaxis

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Although allergic diseases are generally considered to be diseases of childhood and youth, the first symptoms of allergic diseases can be seen in old age sometimes.
📊
Key Findings & Data:Materials and methods: The files of the patients who applied to our clinic’s allergy unit during the 8-year period were retrospectively analyzed.
💡
Conclusion & Impact:There is a need to develop specific guidelines for the diagnosis of allergic diseases in the elderly.Key words: Elderly, allergic diseases, allergic rhinitis, drug hypersensitivity reactions, hymenoptera venom allergy, anaphylaxis
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Although allergic diseases are generally considered to be diseases of childhood and youth, the first symptoms of allergic diseases can be seen in old age sometimes. The aim of this study was to determine the prevalence and characteristics of allergic diseases in the elderly population admitted to the allergy unit on an outpatient basis. Materials and methods: The files of the patients who applied to our clinic’s allergy unit during the 8-year period were retrospectively analyzed. The data of patients aged ≥ 65 years were obtained from the files of our allergy unit archive. Results: A total of 1272 patients aged ≥ 65 years old were included in the study. The mean age was 70 years (range: 65–97 years). Most of the patients were female (n = 704, 55.3%). Of the patients, 887 (69.8%) presented with cutaneous symptoms, and urticaria was identified in 500 of them (56.3%). Drug hypersensitivity reactions were detected in 175 (13.7%) patients. A total of 71 (5.6%) patients had asthma, 65 (5.1%) had anaphylaxis, 48 (3.8%) had allergic rhinitis, 24 (1.9%) had hymenoptera venom allergy, and 18 (1.4%) had food allergies. Atopy history (OR = 2.323, 95% CI = 1.590–3.393, p < 0.001) and comorbidity (OR = 1.631, 95% CI = 1.050–2.533, p = 0.029) were found to be risk factors for drug hypersensitivity reactions. Male sex (OR = 3.462, 95% CI = 1.097–10.933, p = 0.034) and atopy history (OR = 14.877, 95% CI = 6.081–36.393, p < 0.001) were found to be risk factors for hymenoptera venom allergy. Conclusion: Diagnosis becomes difficult due to the perception that allergic diseases mainly affect young people. Clinical symptoms are not evident in the elderly and age-related difficulties are encountered in diagnostic tests. There is a need to develop specific guidelines for the diagnosis of allergic diseases in the elderly.Key words: Elderly, allergic diseases, allergic rhinitis, drug hypersensitivity reactions, hymenoptera venom allergy, anaphylaxis

🔖

Cite This Article

AYTEKİN, G., ÇÖLKESEN, F., YILDIZ, E., ARSLAN, Ş., EVCEN, R., AYKAN, F. S., KILINÇ, M. (2022). Allergic diseases in the elderly population: a single-center experience. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 5, 2631–2640. https://ajindex.com/articles/609434

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Ventura MT, D’Amato A, Giannini M, Carretta A, Tummolo RA et al. Incidence of allergic diseases in an elderly population. Immunopharmacology and Immunotoxicology. 2010
  2. 32 (1): 165-170. doi: 10.3109/08923970903213735 2. Cardona V, Guilarte M, Luengo O, Labrador-Horrillo M, SalaCunill A et al. Allergic diseases in the elderly. Clinical and Translational Allergy. 2011
  3. 1 (1): 11. doi: 10.1186/2045-7022- 1-11 3. Montanaro A. Allergic disease management in the elderly: a wakeup call for the allergy community. Annals of Allergy, Asthma and Immunology. 2000
  4. 85 (2): 85-86. doi: 10.1016/ S1081-1206(10)62442-8 4. Sahin-Yilmaz AA, Corey JP. Rhinitis in the elderly. Clinical Allergy and Immunology. 2007
  5. Dykewicz MS, Lam JK. Drug Hypersensitivity Reactions. Medical Clinics of North America. 2020
  6. 104 (1): 109-128. doi: 10.1016/j.mcna.2019.09.003 6. Cardona V, Ansotegui IJ, Ebisawa M, El-Gamal Y, Fernandez Rivas M et al. World allergy organization anaphylaxis guidance 2020. World Allergy Organization Journal. 2020
  7. 13 (10): 100472. doi: 10.1016/j.waojou.2020.100472 7. Grabenhenrich LB, Dolle S, Moneret-Vautrin A, Kohli A, Lange L et al. Anaphylaxis in children and adolescents: The European Anaphylaxis Registry. Journal of Allergy and Clinical Immunology. 2016
  8. 137 (4): 1128-1137 e1. doi: 10.1016/j. jaci.2015.11.015 8. Leus AJG, Meijer JM, Zuidema SU, Jonkman MF. [Pruritus in elderly: diagnosis and treatment]. Nederlands Tijdschrift voor Geneeskunde. 2018
  9. Ban GY, Kim MY, Yoo HS, Nahm DH, Ye YM et al. Clinical features of elderly chronic urticaria. The Korean Journal of Internal Medicine. 2014
  10. 29 (6): 800-806. doi: 10.3904/ kjim.2014.29.6.800 10. Agostoni A, Cicardi M. Drug-induced angioedema without urticaria. Drug Safety. 2001
  11. 24 (8): 599-606. doi: 10.2165/00002018-200124080-00004 11. Madsen F, Attermann J, Linneberg A. Epidemiology of nonhereditary angioedema. Acta Dermato-Venereologica. 2012
  12. 92 (5): 475-479. doi: 10.2340/00015555-1389 12. Vasekar M, Craig TJ. ACE inhibitor-induced angioedema. Current Allergy and Asthma Reports. 2012
  13. 12 (1): 72-78. doi: 10.1007/s11882-011-0238-z 13. Kostis JB, Kim HJ, Rusnak J, Casale T, Kaplan A et al. Incidence and characteristics of angioedema associated with enalapril. Archives of Internal Medicine. 2005
  14. 165 (14): 1637-1642. doi: 10.1001/archinte.165.14.1637 14. Lefebvre J, Murphey LJ, Hartert TV, Jiao Shan R, Simmons WH et al. Dipeptidyl peptidase IV activity in patients with ACEinhibitor-associ